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Abstract
We present the first case of a head and neck oncological procedure accomplished in a Jehovah’s Witness using
the Ultracision Harmonic Scalpel (Ethicon, Cincinnati, OH). Jehovah’s Witnesses present a serious challenge to the
head and neck cancer surgeon due to their refusal to accept transfusion of any blood products. However, our
experience reinforces the view that surgical management of head and neck cancer is possible in these patients.
We show the Harmonic Scalpel, an ultrasonic tissue dissector, to be a useful surgical tool in obviating the need for
blood transfusion. Preoperative optimisation, intra-operative surgical and anaesthetic techniques are also fully
discussed.
Keywords: Harmonic scalpel, Head and neck cancer, Jehovah’s Witness
Background
Jehovah’s Witnesses (JW) are a substantial Christian
denomination, numbering up to 7 million with a pre-
sence in almost all countries worldwide. They are gov-
e r n e db yag r o u po fe l d e r se x e r c i s i n ga u t h o r i t yo na l l
doctrinal matters based on their own translation of the
bible. Of particular relevance to medical practice is their
refusal, since 1945, to accept blood transfusions even in
cases of medical emergency [1] This has been the centre
of a number of high profile medical ethics cases [2].
The Harmonic Scalpel (HS), an ultrasonic dissector coa-
gulator (Figure 1; Ethicon, Cincinnati, OH), is a new
surgical tool which simultaneous cuts and coagulates tis-
sues. Here we report a case of a large oral cancer and
neck dissection with free flap reconstruction performed
in a JW with the HS obviating the need for blood
products.
Case presentation
A 48 year old female Caucasian JW presented with non-
healing ulcerated lower right second and third molar
extraction sockets in 2005. Her past medical history was
unremarkable. She was a non-smoker and consumed
only moderate amounts of alcohol in accordance with
her religious beliefs. Biopsy was performed confirming a
moderately differentiated squamous cell carcinoma
(SCC), staged by whole body computed tomography
(CT) as T4N0M0. She was initially treated with primary
chemoradiotherapy as blood products were deemed to
be essential for surgical resection at this time. She
received 63 Grays of radiation and 5 cycles of cisplatin.
Post-treatment she was deemed to be tumor free.
In 2006 she presented with an unstable ulcer on the
left lateral tongue. Biopsy revealed early invasive pT1
SCC. This was treated with laser excision.
She was followed up at monthly intervals, however, in
2009 she presented with a lower right retromolar mass
eroding into the mandible (Figure 2, Panorex image).
Biopsy revealed Human Papiloma Virus (HPV) negative
SCC staged at CT as T4N0M0. Treatment plans were
devised after extensive discussion at the Head and Neck
Cancer Multi-Disciplinary Team (MDT) meeting. This
case was particularly complex given the previous che-
moradiotherapy and the inability to use blood products
in the case of severe blood loss. Salvage surgery was
deemed most appropriate with the proviso that new sur-
gical techniques could now minimize blood loss.
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ducts all efforts were directed at preoperatively optimi-
sation and minimization of intra-operative blood loss.
Preoperative blood tests showed haemoglobin (Hb) of
11 g/dl, platelets 310 × 10
9/l and a normal clotting pro-
file. She was assessed by a haematologist who prescribed
a 2 week preoperative course of oral ferrous sulphate.
No further preoperative treatment was instigated.
At operation the patient was premedicated with a
statim dose of 1 gram tranexamic acid and anaesteth-
seia was induced with a combination of propofol (120
mg), fentanyl (100 mcg) and vecuronium (8 mg).
Anaesthesia was maintained using a remifentanil infu-
s i o n( 5 0m c g / m la t1 0m l / h r )a n ds e v o f l u o r a n eg a s
inhalation. Hypervolameic hemodilution was performed
using preloading with 15 ml/kg cryastalloid fluid in
conjunction with the controlled hypotension using
remifentanil infusion maintaining a mean arterial pres-
sure of 65 mmHg. The patient was placed in a head
up position and meticulous attention to blood loss was
performed throughout the whole operation. Blood loss
was charted continuously during the operation. Intra-
operative blood sampling also provided a guide to
blood loss and the Hb did not drop below 9.6 g/dl
during the operation. The intraoperative clotting pro-
file revealed a normal prothrombin (PT) and activated
partial throboplastin time (APTT).
A left tonsillar and retromolar with mandibular rim
resection was undertaken and reconstructed with a
radial forearm free flap (Figure 3, resection specimen).
A left level I-IV neck dissection and covering tracheost-
omy was also performed (Figure 4, neck dissection). The
surgeon (JA) used the HS throughout the procedure.
The radial forearm flap was raised by the Plastics Surgi-
cal team (KS) using a standard technique with cold steel
dissection.
The entire procedure was accomplished in approxi-
mately 11 hours. The total blood loss was under 500 ml.
During the operation Hartmann’s solution was infused
at 100 ml/hr (Total 1.1 L). The urine output was 500 ml
giving an intra-operative fluid balance of +0.1 L.
The patient was transferred to the intensive care unit
for close monitoring on the first postoperative night.
She was then returned to the specialised otolaryngology
ward. The patient had a single episode of self resolving
supraventricular tachycardia but the rest of the post-
operative course was uneventful. She was discharged
home able to eat a soft diet and with good speech func-
tion 2 weeks postoperatively. Her postoperative haemo-
globin did not drop below 10 g/dl on her daily
postoperative blood counts. No blood products were
used at any time.
Discussion
The use of a blood transfusion is forbidden under JW
doctrine. Doctors have no legal right to transfuse some-
one against their will even if this may result in their
death [3]. After extensive discussion at the MDT meet-
ing and with the patient, a comprehensive literature
review was undertaken by the operating surgeons. In
conjunction with their previous experience of decreased
blood loss whilst using the HS it was decided that sal-
vage surgery was the most appropriate course of action.
Figure 1 Ultracision Harmonic Scalpel (Ethicon, Cincinnati, OH).
http://www.ethiconendosurgery.com/Clinician/Product/energy/.
Figure 2 Panorex image demonstrating lower right retromolar
mass eroding into the mandible (2009).
Figure 3 Left tonsillar and retromolar with mandibular rim
resection specimen marked with surgical pins to allow
orientation by histopathologist.
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known to be associated with a number of risks. These
must be balanced against the potential benefit of transfu-
sion. Reactions range from the self-limiting febrile non-
hemolytic transfusion reaction to life threatening condi-
tions such as Transfusion Related Acute Lung Injury
(TRALI)[4]. The transmission of blood borne bacteria
and viruses (including HIV and hepatitis B/C) also
remains a possibility [5,6]. Specifically in surgical patients
there is a documented link between transfusions and
postoperative infections and tumor recurrence [7].
According to the literature, blood transfusion is
required in 14-80% of all head and neck cancer opera-
tions [8]. However, within our unit only 16% of major
head and neck operations required blood transfusion
(11 of 68 cases transfused between August 2008-August
2009). We have also noted a significant decline in the
use of transfusion since we began to use the HS (unpub-
lished data).
In the preoperative and intra-operative periods hyper-
volameic/normovolemic hemodiltion [9], hypotensive
anaesthesia [10] and cell scavenging [11] have all been
described to minimize blood loss. Acute normovolemic
hemodilution is the process of removing one or more
units of blood before the operation for transfusion to
the patient either during or at the end of the operation.
This was not acceptable to our patient as blood cannot
be reused once taken out of circulation. On discussion
with our patient cell scavenging was also ruled out as it
involves the reinfusion of blood which has left the circu-
lation. We decided on a strategy of hypervolemic hemo-
dilution. Here considerable fluid is administered
intravenously to the patient reducing the patient’s hema-
tocrit and hence the blood’s oxygen carrying capability.
This reduces the number of red blood cells lost intra-
operatively. The hematocrit is restored with a postopera-
tive diuresis. This strategy is not suitable for patients
with cardiovascular or renal dysfunction [9]. We also
used controlled hypotension with a mean arterial pres-
sure of 65 mmHg maintained with an opiate infusion.
Similarly, the use of controlled hypotension is only
recommended in patients known to be free of cardiovas-
cular and respiratory problems [10].
The use of aprotinin and tranxemic acid have also
been employed to reduce intra-operative bleeding [12].
Previous surgery in JW have used aprotinin, a bovine
derived inhibitor of trypsin and plasmin. However, this
was withdrawn in May 2008 due an increased risk of
death in cardiac surgical patients [13]. Therefore we fol-
lowed the recommendation of Henry et al to use the
antifibrinolytic agent tranxemic acid. Their meta-analysis
showed this to be the most effective antifibinolytic since
the withdrawl of aprotinin [12].
There are only a few documented cases of JWs under-
going major head and neck surgery previously presented
in the literature. Genden et al present the case of a 35
year old male with a T3N0M0 anterior floor of mouth
SCC who successfully underwent a segmented mandibu-
lectomy and staged fibula free flap reconstruction with
osseointegrated dental implants without use of allogenic
blood [14]. Van Hemelen et al present two JWs with
oral cancer requiring neck dissection and free flap trans-
fer without use of blood transfusion [15]. Skoner et al’s
presentation of 5 JWs with head and neck cancers
requiring 7 free flap reconstructions is the largest series
in the literature so far [16]. However, our case is the
first presentation of the use of the HS in this patient
population.
Preoperative planning requires extensive discussion
between all parties involved. Particularly, the patient
must be aware that refusal of blood products may have
life endangering consequences. Our patient was fully
optimized before surgery. A full medical and surgical
history was taken to identify any risk factors adversely
affecting hemostasis. We restricted pre- and post-
Figure 4 Intra-operative image demonstrating a left level I-IV
neck dissection performed with the Harmonic Scalpel.
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moglobin was optimized by a course of ferrous sulphate.
We considered the use of recombinant erythropoientin
(EPO), to raise preoperative haemoglobin levels. EPO is
a glycosylated polypeptide released by the kidney in
response to hypoxia which increases erythropoietic pre-
cursors in the bone marrow and has been shown to be a
useful in avoiding transfusion in surgical specialties
including head and neck [17,18]. Remmers et al sug-
gested the use of EPO and iron 2 to 3 weeks before
elective surgery in JW [19].
However, the use of EPO has been associated with
increased recurrence in head and neck cancer patients
[20]. Janecka speculates that this may be due to EPO
promoting thrombogenesis and hence tumor hypoxia
and angiogenesis [21]. Conversely, a more recent trial
failed to shown any negative impact of EPO therapy on
patient survival or tumor recurrence [22]. We decided
against the use of EPO in this case. The use of recombi-
nant clotting factors and DDAVP was also thought inap-
propriate in a patient with a physiologically normal
clotting profile.
With our unit’s experience of the HS and a compre-
hensive literature review we felt the use of the HS
would allow meticulous hemostatis and thus reduce the
chances of requiring blood products. The traditional
surgical method for head and neck cancer resections is
‘cold steel’ dissection. Here blood loss is controlled
using pressure or ligatures. Monopolar and bipolar elec-
trosurgery are newer methods of dissection which use
heat to cauterise bleeding vessels. The HS is a surgical
cutting device which concurrently coagulates tissues.
The basic principle of this device is converting an ultra-
sonic wave into high frequency mechanical energy,
vibrating the cutting surfaces at 55.5 Khz. The cutting
blade is able to denature proteins into a coagulum
which acts as a haemostatic seal around blood vessels
[23]. This allows optimal surgical visibility in a near
bloodless operating field [24]. The harmonic scalpel
operates at lower temperatures (50-100 C) compared to
mono- or bipolar devices (100-600 C) hence there is
less tissue damage and the subsequent inflammatory
response is also lessened. The lower operating tempera-
tures mean that neighbouring structures are at less risk
of damage hence allowing the surgeon to work around
delicate structures [25].
There is also less eschar formation and hence less
smoke production. Due to the lower temperatures of
the harmonic scalpel as compared to conventional ther-
mal surgical instruments less tissue sticks to the blades.
This decreases tissue damage and wasted time cleaning
and exchanging instruments [26,27].
An u m b e ro fs t u d i e sh a v es h own that operative time,
blood loss and hospital stay are shortened in a wide
range of head and neck such as tonsillectomy [28] and
thyroidectomy [25-27], general [29] and gynaecological
surgery [30]. Initial results have been favourable with
less postoperative pain, lower blood loss, shortened
operative time and lack of impairment of histopatholo-
gic evaluation.
Salami et al present a non-randomized study compar-
ing 40 pharyngolarygectomy, 40 total laryngectomy, 40
unilateral neck dissections and 40 superficial parotidec-
tomies with either the harmonic scalpel or ‘cold steel’
dissection [31]. The evaluation demonstrated a signifi-
cant decrease in operative time, intra-operative blood
loss, total hospital stay, postoperative seroma formation
and subjective pain scores for patients treated with the
HS.
Conclusions
In summary, JW present a major challenge to the head
and neck cancer surgeon. We believe preoperative opti-
misation with ferrous sulphate, the use of hypervolameic
hemodilution with the addition of tranexamic acid and
meticulous attention to intra-operative hemostasis with
the HS are the cornerstones of management for these
patients. We found the use of the HS in conjunction
with our anaesthetic techniques created an almost
bloodless operating field and enabled a large cancer
resection and reconstruction to be performed without
recourse to blood transfusion. We feel the HS will play
an important role in bloodless surgery in the future.
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